High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$17.0M
$16,974,908
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TCRX
P
TScan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-12-23
$5,602
|
||||||
| TCRX |
TScan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-12-23 | $5,602 | P | Form 4 |
|
TCRX
P
TScan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-12-22
$67,950
|
||||||
| TCRX |
TScan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-12-22 | $67,950 | P | Form 4 |
|
TCRX
P
TScan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-12-19
$71,974
|
||||||
| TCRX |
TScan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-12-19 | $71,974 | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-28
$1,391,686Large
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-28 | $1,391,686Large | P | Form 4 |
|
NEUP
P
Neuphoria Therapeutics Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary BuyΔOwn +270.6%
2025-10-21
$3,283,108Large
|
||||||
| NEUP |
Neuphoria Therapeutics Inc.
|
10% Owner
Discretionary BuyΔOwn +270.6%
|
2025-10-21 | $3,283,108Large | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-17
$252,565
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-17 | $252,565 | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-16
$1,328,250Large
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-16 | $1,328,250Large | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-15
$409,049
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-15 | $409,049 | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-14
$114,048
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-14 | $114,048 | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-10
$2,041,385Large
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-10 | $2,041,385Large | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-09
$4,191,859Large
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-09 | $4,191,859Large | P | Form 4 |
|
CGEM
P
Cullinan Therapeutics, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-10-08
$3,593,698Large
|
||||||
| CGEM |
Cullinan Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-08 | $3,593,698Large | P | Form 4 |
|
PASG
P
Passage BIO, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-09-15
$83,175
|
||||||
| PASG |
Passage BIO, Inc.
|
10% Owner
Discretionary Buy
|
2025-09-15 | $83,175 | P | Form 4 |
|
PASG
P
Passage BIO, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-09-12
$138,299
|
||||||
| PASG |
Passage BIO, Inc.
|
10% Owner
Discretionary Buy
|
2025-09-12 | $138,299 | P | Form 4 |
|
PASG
P
Passage BIO, Inc.
Lynx1 Capital Management LP
• 10% Owner
Discretionary Buy
2025-09-11
$2,261
|
||||||
| PASG |
Passage BIO, Inc.
|
10% Owner
Discretionary Buy
|
2025-09-11 | $2,261 | P | Form 4 |